 DURHAM, NC ACCESSWIRE March 8, 2021 Heat Biologics, Inc. NASDAQ:HTBX, a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announced that Jeff Wolf, CEO of Heat Biologics, has been invited to present at Inaugural Emerging Growth Virtual Conference , hosted by M Vest LLC and Maxim Group LLC. The presentation will be available to all registered participants of the conference link on March 17th - 19th and will be posted on Heat Biologics website link after March 19th. 